<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d62" origId="L-Histidine"><sentence id="DrugDDI.d62.s0" origId="s0" text="Medroxyprogesterone Acetate - L-histidine was observed to enhance (in tissue culture) the effect of medroxyprogesterone acetate in reducing the number of human breast cancer cells that were in the S phase."><entity charOffset="0-27" id="DrugDDI.d62.s0.e0" origId="s0.p0" text="Medroxyprogesterone Acetate" type="drug"/><entity charOffset="100-127" id="DrugDDI.d62.s0.e1" origId="s0.p9" text="medroxyprogesterone acetate" type="drug"/><pair e1="DrugDDI.d62.s0.e0" e2="DrugDDI.d62.s0.e1" id="DrugDDI.d62.s0.p0" interaction="true"/></sentence><sentence id="DrugDDI.d62.s1" origId="s1" text="H1 and H2 Blockers - Although not reported, L-histidine, via its metabolism to histamine, might decrease the efficacy of H1 and H2 blockers."><entity charOffset="7-18" id="DrugDDI.d62.s1.e0" origId="s1.p17" text="H2 Blockers" type="drug"/><entity charOffset="44-55" id="DrugDDI.d62.s1.e1" origId="s1.p22" text="L-histidine" type="drug"/><entity charOffset="128-139" id="DrugDDI.d62.s1.e2" origId="s1.p30" text="H2 blockers" type="drug"/><pair e1="DrugDDI.d62.s1.e0" e2="DrugDDI.d62.s1.e1" id="DrugDDI.d62.s1.p0" interaction="false"/><pair e1="DrugDDI.d62.s1.e0" e2="DrugDDI.d62.s1.e2" id="DrugDDI.d62.s1.p1" interaction="false"/><pair e1="DrugDDI.d62.s1.e1" e2="DrugDDI.d62.s1.e2" id="DrugDDI.d62.s1.p2" interaction="true"/><negationtags>H1 and H2 Blockers - Although &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; reported&lt;/xcope&gt;, L-histidine, via its metabolism to histamine, might decrease the efficacy of H1 and H2 blockers.</negationtags></sentence></document>